Prevention of drug-induced Bone Necrosis in the oral cavity in Cancer patients undergoing Tooth Removal – randomized clinical trial

Not Applicable

Recruiting

• Conditions: C05.116.852; Bisphosphonate-Associated Osteonecrosis of the Jaw

• Registration Number: RBR-4zsh6g8
• Lead Sponsor: Sociedade Pernambucana de Combate ao Câncer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-03
• Last Update Posted: 29 April 2024
• Study Completion: 2026-01-02

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients over 18 years of age; both genders; presence of teeth requiring simple extraction; patient submitted to medications that induce osteonecrosis of the jaw for antineoplastic treatment

Exclusion Criteria

Patients who underwent radiotherapy treatment in the head and neck region; patient diagnosed with metastasis in gnathic bones; patients with any known contraindications or allergies to methylene blue or some of the prescribed medications; patients with any clinical impediment to performing photobiomodulation

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected that photodynamic therapy will have a prophylactic effect on the development of drug-induced osteonecrosis of the jaw in cancer patients undergoing tooth extraction.

Secondary Outcome Measures

Name	Time	Method
o secondary outcomes are expected.